Jazz Pharmaceuticals plc (JAZZ) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $15.62B, a trailing price-to-earnings ratio of 9.0 and a free-cash-flow yield of 7.8%. Over the most recent reported fiscal year, revenue grew 4.9% and free cash flow per share fell 8.0%.